A Computed Tomography Analysis of the Success of Spinal Fusion Using Ultra-Low Dose (0.7 mg per Facet) of Recombinant Human Bone Morphogenetic Protein 2 in Multilevel Adult Degenerative Spinal Deformity Surgery.

Conclusions: To our knowledge, this is the first study to report a CT that defined 92%-98% FF and 100% IBF using the lowest reported dose of RhBMP-2 in multilevel ASD surgery. The use of ultra-low dose RhBMP-2 reduces the RhBMP-2 related complications and healthcare costs. PMID: 30322256 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30322256?dopt=Abstract

Source: Asian Spine Journal - October 17, 2018 Category: Orthopaedics Tags: Asian Spine J Source Type: research